(S1 (S (NP (JJ GATA3-Driven) (NN Th2) (NNS Responses)) (VP (VBP Inhibit) (NP (NP (JJ TGF-beta1-Induced) (NN FOXP3) (NN Expression)) (CC and) (NP (NP (DT the) (NN Formation)) (PP (IN of) (NP (JJ Regulatory) (NN T) (NNS Cells))))))))
(S1 (S (S (S (NP (NN Transcription) (NNS factors)) (VP (VBP act) (PP (IN in) (NP (NN concert))) (S (VP (TO to) (VP (VB induce) (NP (NP (NN lineage) (NN commitment)) (PP (IN towards) (NP (NP (NN Th1)) (, ,) (NP (NN Th2)) (, ,) (CC or) (NP (NN T) (JJ regulatory) (-LRB- -LRB-) (NN Treg) (-RRB- -RRB-) (NNS cells)))))))))) (, ,) (CC and) (S (NP (PRP$ their) (JJ counter-regulatory) (NNS mechanisms)) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ critical) (PP (IN for) (NP (NP (NN polarization)) (PP (IN between) (NP (NP (NN Th1)) (CC and) (NP (NN Th2)) (NP (NNS phenotypes)))))))))))))) (. .)))
(S1 (S (S (NP (NN FOXP3)) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN transcription) (NN factor)) (PP (IN for) (NP (NP (ADJP (JJ natural))) (, ,) (NP (NP (JJ thymus-derived)) (PRN (-LRB- -LRB-) (NP (NN nTreg)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ inducible) (NN Treg)) (PRN (-LRB- -LRB-) (NP (NN iTreg)) (-RRB- -RRB-))) (NP (NN commitment))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (NNS mechanisms)) (VP (VBG regulating) (NP (PRP$ its) (NN expression)))) (VP (VBP are) (ADJP (ADVP (RB as) (RB yet)) (JJ unknown)))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN mechanism)) (VP (VBG controlling) (NP (NP (NN iTreg) (NN polarization)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN overruled) (PP (IN by) (NP (DT the) (NN Th2) (NN differentiation) (NN pathway)))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NP (NN interleukin) (CD 4)) (PRN (-LRB- -LRB-) (NP (NN IL-4)) (-RRB- -RRB-))) (ADJP (JJ present) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN T) (NN cell) (NN priming))))))) (VP (VBZ inhibits) (NP (NN FOXP3))))))) (. .)))
(S1 (S (S (NP (DT This) (JJ inhibitory) (NN mechanism)) (VP (VBD was) (ADVP (RB also)) (VP (VBN confirmed) (PP (PP (IN in) (NP (NN Th2) (NNS cells))) (CC and) (PP (IN in) (NP (NP (NN T) (NNS cells)) (PP (IN of) (NP (NP (JJ transgenic) (NNS mice)) (VP (VBG overexpressing) (NP (NP (NN GATA-3)) (PP (IN in) (NP (NN T) (NNS cells))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NP (NN transforming) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TGF)) (-RRB- -RRB-))) (JJ -beta-mediated) (NN FOXP3) (NN induction))))))))))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN inhibition)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (JJ direct) (NN binding)) (PP (IN of) (NP (NN GATA3))) (PP (TO to) (NP (NP (DT the) (NN FOXP3) (NN promoter)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ represses) (NP (PRP$ its) (NN transactivation) (NN process)))))))))))) (. .)))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT this) (NN study)) (VP (VBZ provides) (NP (NP (DT a) (JJ new) (NN understanding)) (PP (IN of) (NP (NN tolerance) (NN development))) (, ,) (VP (VBN controlled) (PP (IN by) (NP (DT a) (NN type) (CD 2) (JJ immune) (NN response))))))) (. .)))
(S1 (S (S (NP (NP (NN IL-4) (NN treatment)) (PP (IN in) (NP (NNS mice)))) (VP (VBZ reduces) (NP (NN iTreg) (NN cell) (NN frequency)) (, ,) (S (VP (VBG highlighting) (SBAR (IN that) (S (NP (NP (JJ therapeutic) (NNS approaches)) (SBAR (WHNP (WDT that)) (S (VP (VBP target) (NP (NP (NN IL-4)) (CC or) (NP (NN GATA3))))))) (VP (MD might) (VP (VB provide) (NP (JJ new) (JJ preventive) (NNS strategies)) (S (VP (VBG facilitating) (NP (NN tolerance) (NN induction)) (PP (ADVP (RB particularly)) (IN in) (NP (NP (JJ Th2-mediated) (NNS diseases)) (, ,) (PP (JJ such) (IN as) (NP (NN allergy))))))))))))))) (. .)))
